Perspectives on Supporting the Healthcare Supply Chain

This technical report discusses the challenges and opportunities in managing working capital within the healthcare supply chain, particularly in the pharmaceutical and medical device sectors. It outlines the impact of supply chain disruptions since the COVID-19 pandemic and emphasizes the importance of effective working capital management for organizations aiming to innovate and meet evolving market demands. The document details the cash conversion cycles in the pharmaceutical sector, highlighting the longer cash conversion cycles due to high levels of inventory and payment terms. It also presents case studies of companies that have successfully optimized their working capital through strategies such as payment term harmonization and supply chain finance programs. Additionally, the report examines the role of working capital management in funding research and development initiatives, noting the significant investments made by healthcare companies in R&D. The analysis is supported by data from S&P Global, illustrating trends in cash flow and R&D spending in the industry.